Hepatic mitochondrial dysfunction in Friedreich Ataxia

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Stüwe, Sven H ^a   Goetze, Oliver ^a,b   Arning, Larissa ^c   Banasch, Matthias ^a   Schmidt, Wolfgang E ^a   Schöls, Ludger ^d,e   Saft, Carsten ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

13c methionine; Ataxia; Breath test; Friedreich; Neurodegeneration

Indexed keywords

CARBON 13; METHIONINE;

ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXHALATION; FEMALE; FRIEDREICH ATAXIA; HUMAN; LIVER METABOLISM; LIVER MITOCHONDRION; MALE;

EID: 81055149764     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-145     Document Type: Article

References (19)

1. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science New York, NY 1996, 271(5254):1423-1427.
2. Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 1997, 17(2):215-217. 10.1038/ng1097-215, 9326946.
3. Koutnikova H, Campuzano V, Foury F, Dolle P, Cazzalini O, Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nature genetics 1997, 16(4):345-351. 10.1038/ng0897-345, 9241270.
4. Schulz JB, Dehmer T, Schols L, Mende H, Hardt C, Vorgerd M, Burk K, Matson W, Dichgans J, Beal MF, et al. Oxidative stress in patients with Friedreich ataxia. Neurology 2000, 55(11):1719-1721.
5. Filla A, De Michele G, Cavalcanti F, Pianese L, Monticelli A, Campanella G, Cocozza S. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. American journal of human genetics 1996, 59(3):554-560. 1914893, 8751856.
6. Schols L, Amoiridis G, Przuntek H, Frank G, Epplen JT, Epplen C. Friedreich's ataxia. Revision of the phenotype according to molecular genetics. Brain 1997, 120(Pt 12):2131-2140.
7. Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006, 66(11):1717-1720. 10.1212/01.wnl.0000219042.60538.92, 16769946.
8. Vorgerd M, Schols L, Hardt C, Ristow M, Epplen JT, Zange J. Mitochondrial impairment of human muscle in Friedreich ataxia in vivo. Neuromuscul Disord 2000, 10(6):430-435. 10.1016/S0960-8966(00)00108-5, 10899450.
9. Della Nave R, Ginestroni A, Giannelli M, Tessa C, Salvatore E, Salvi F, Dotti MT, De Michele G, Piacentini S, Mascalchi M. Brain structural damage in Friedreich's ataxia. Journal of neurology, neurosurgery, and psychiatry 2008, 79(1):82-85. 10.1136/jnnp.2007.124297, 17634216.
10. Milazzo L, Piazza M, Sangaletti O, Gatti N, Cappelletti A, Adorni F, Antinori S, Galli M, Moroni M, Riva A. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother 2005, 55(1):84-89.
11. Armuzzi A, Candelli M, Zocco MA, Andreoli A, De Lorenzo A, Nista EC, Miele L, Cremonini F, Cazzato IA, Grieco A, et al. Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther 2002, 16(12):1977-1996. 10.1046/j.1365-2036.2002.01374.x, 12452932.
12. Banasch M, Emminghaus R, Ellrichmann M, Schmidt WE, Goetze O. Longitudinal effects of hepatitis C virus treatment on hepatic mitochondrial dysfunction assessed by C-methionine breath test. Aliment Pharmacol Ther 2008, 28(4):443-449. 10.1111/j.1365-2036.2008.03745.x, 18513202.
13. Banasch M, Frank J, Serova K, Knyhala K, Kollar S, Potthoff A, Brockmeyer NH, Goetze O. Impact of antiretroviral treatment on (13)C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study. HIV Med 2010,
14. Wutzke KD, Forberger A, Wigger M. Effect of alcohol consumption on the liver detoxication capacity as measured by [13C]methacetin- and [methyl-13C]methionine-breath tests. Isotopes Environ Health Stud 2008, 44(2):219-226. 10.1080/10256010802066372, 18569193.
15. Banasch M, Knyhala K, Kollar S, Serova K, Potthoff A, Schlottmann R, Schmidt WE, Brockmeyer NH, Goetze O. Disease- and treatment-related predictors of hepatic mitochondrial dysfunction in chronic HIV infection assessed by non-invasive (13)C-methionine breath test diagnostic. Eur J Med Res 2008, 13(9):401-408.
16. Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AH. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Human molecular genetics 2000, 9(2):275-282. 10.1093/hmg/9.2.275, 10607838.
17. Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia 2007, 62(7):690-701. 10.1111/j.1365-2044.2007.05055.x, 17567345.
18. Konig SA, Schenk M, Sick C, Holm E, Heubner C, Weiss A, Konig I, Hehlmann R. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults. Epilepsia 1999, 40(7):1036-1040. 10.1111/j.1528-1157.1999.tb00814.x, 10403231.
19. Delatycki MB, Paris DB, Gardner RJ, Nicholson GA, Nassif N, Storey E, MacMillan JC, Collins V, Williamson R, Forrest SM. Clinical and genetic study of Friedreich ataxia in an Australian population. American journal of medical genetics 1999, 87(2):168-174. 10.1002/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2, 10533031.